302 related articles for article (PubMed ID: 16702495)
1. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
Tsai EY; Taur A; Espinosa L; Quon A; Johnson D; Dick S; Chow S; Advani R; Warnke R; Kohler S; Hoppe RT; Kim YH
Arch Dermatol; 2006 May; 142(5):577-84. PubMed ID: 16702495
[TBL] [Abstract][Full Text] [Related]
2. Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
Dan S; Qiang G; Shu-Xia W; Chang-Hong L
Eur J Radiol; 2015 Jul; 84(7):1293-8. PubMed ID: 25982461
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
4. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
Hodak E; Sherman S; Papadavid E; Bagot M; Querfeld C; Quaglino P; Prince HM; Ortiz-Romero PL; Stadler R; Knobler R; Guenova E; Estrach T; Patsatsi A; Leshem YA; Prague-Naveh H; Berti E; Alberti-Violetti S; Cowan R; Jonak C; Nikolaou V; Mitteldorf C; Akilov O; Geskin L; Matin R; Beylot-Barry M; Vakeva L; Sanches JA; Servitje O; Weatherhead S; Wobser M; Yoo J; Bayne M; Bates A; Dunnill G; Marschalko M; Buschots AM; Wehkamp U; Evison F; Hong E; Amitay-Laish I; Stranzenbach R; Vermeer M; Willemze R; Kempf W; Cerroni L; Whittaker S; Kim YH; Scarisbrick JJ;
Br J Dermatol; 2021 Mar; 184(3):524-531. PubMed ID: 32574377
[TBL] [Abstract][Full Text] [Related]
5. Integrated positron-emission tomography and computed tomography manifestations of cutaneous T-cell lymphoma.
Kamstrup MR; Gniadecki R; Friberg L
Arch Dermatol; 2012 Dec; 148(12):1420-2. PubMed ID: 23247490
[No Abstract] [Full Text] [Related]
6. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
Sausville EA; Worsham GF; Matthews MJ; Makuch RW; Fischmann AB; Schechter GP; Gazdar AF; Bunn PA
Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
[TBL] [Abstract][Full Text] [Related]
7. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE
Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
11. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.
Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF
Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sézary syndrome in the southeastern United States: a single-institution cohort.
Desai M; Liu S; Parker S
J Am Acad Dermatol; 2015 Feb; 72(2):276-85. PubMed ID: 25458019
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
14. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer.
Lin WY; Hsu WH; Lin KH; Wang SJ
J Chin Med Assoc; 2012 May; 75(5):203-8. PubMed ID: 22632985
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous lymphomas].
Ingen-Housz-Oro S; Bagot M
Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic imaging in the initial staging of mycosis fungoides and Sézary syndrome.
Kulin PA; Marglin SI; Shuman WP; Chew DE; Olerud JE
Arch Dermatol; 1990 Jul; 126(7):914-8. PubMed ID: 2360839
[TBL] [Abstract][Full Text] [Related]
18. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome.
Toro JR; Stoll HL; Stomper PC; Oseroff AR
J Am Acad Dermatol; 1997 Jul; 37(1):58-67. PubMed ID: 9216524
[TBL] [Abstract][Full Text] [Related]
20. Value of High-Frequency Ultrasound in Accurate Staging of Mycosis Fungoides/Sézary Syndrome.
Wang Y; Niu Z; Liu J; Zhu Q; Liu Z; Liu Y; Jin H
J Ultrasound Med; 2020 Oct; 39(10):1927-1937. PubMed ID: 32319698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
